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Abstract: Growing evidence suggests that diet alteration affects sleep, but this has not yet been
studied in adults with insomnia symptoms. We aimed to determine the effect of a six-month diet
intervention on sleep among overweight and obese (Body mass index, BMI ≥ 25 kg/m2) men with
chronic insomnia symptoms. Forty-nine men aged 30–65 years with chronic insomnia symptoms
were randomized into diet (n = 28) or control (n = 21) groups. The diet group underwent a six-month
individualized diet intervention with three face-to-face counseling sessions and online supervision
1–3 times per week; 300–500 kcal/day less energy intake and optimized nutrient composition were
recommended. Controls were instructed to maintain their habitual lifestyle. Sleep parameters were
determined by piezoelectric bed sensors, a sleep diary, and a Basic Nordic sleep questionnaire.
Compared to the controls, the diet group had shorter objective sleep onset latency after intervention.
Within the diet group, prolonged objective total sleep time, improved objective sleep efficiency, lower
depression score, less subjective nocturnal awakenings, and nocturia were found after intervention.
In conclusion, modest energy restriction and optimized nutrient composition shorten sleep onset
latency in overweight and obese men with insomnia symptoms.
Keywords: insomnia symptoms; sleep; sleep onset; diet intervention; nutrient; overweight; obesity
1. Introduction
Insomnia is a highly prevalent sleep disorder and has become a significant health issue in many
countries. The prevalence of chronic insomnia symptoms classified by the Diagnostic and Statistical
Manual of Mental Disorders, 4th Edition (DSM-IV) criteria ranges between 15.2% and 22.1% of the
general population in different regions of the world [1–3]. In Finland, nearly a quarter of the employed
people are reported to suffer from insomnia [4]. Insomnia symptoms are risk factors of various
adverse health consequences [5]. For instance, difficulty initiating sleep, the symptom represented
by prolonged sleep onset latency (SOL), is independently associated with all-cause mortality among
Finnish men [6].
A growing body of evidence suggests that overweight and obesity are significant risk factors
for impaired sleep and insomnia [7–9]. Population-based study showed that obese adults had higher
incidence of subjective sleep disturbances than non-obese ones [9]. Longitudinal studies suggested
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that both obesity and weight gain could predict future development of insomnia symptoms [7,8].
Diet is an important mediator between sleep and overweight/obesity. Growing evidence suggest
that diet alterations can directly influence sleep parameters [10,11]. Furthermore, the associations
between nutrients and insomnia symptoms have been reported by recent studies [12–14]. However,
no previous study has investigated whether diet intervention leads to improved sleep parameters
related to insomnia symptoms, such as sleep onset latency. There is also a lack of data regarding the
effects of diet-induced weight loss on sleep among overweight and obese populations, especially in
men, among which the combined prevalence of overweight and obesity is higher than women in
Finland [15].
Thus, the present study aimed to investigate whether sleep parameters among overweight and
obese men with chronic insomnia symptoms can be improved through a six-month diet intervention.
We hypothesized that reduced energy intake and optimized nutrient composition can improve one or
multiple objectively and subjectively measured sleep parameters.
2. Methods
The present randomized controlled trial forms part of a larger study with different lifestyle
interventions on middle-aged men with sleep disorders (Monitoring and treatment of obesity-related
sleep disorders, ISRCTN77172005). Results regarding the comparisons between exercise and control
groups have been reported in an earlier publication [16]. In the present paper, we focus solely on
the comparison between diet and control groups. However, to give an overall picture of the study,
baseline characteristics and sleep outcomes at baseline and six months across the three groups are
summarized in Tables S1 and S2. The study was approved by the Ethics Committee of the Central
Finland Health Care District (7/2011). Informed consent was obtained from all participants prior to
the baseline measurements and a copy of the signed consent form was archived.
2.1. Participants
Participants were 49 Finnish men aged 30–65 years with chronic (three months or longer)
complaints of insomnia symptoms. Ninety-four percent (n = 46) of them had BMI ≥ 25 kg/m2.
Participants were voluntarily recruited through the outpatient clinics and public health care centers in
the Central Finland Health Care District, or through advertising on the local radio news media and the
Internet. The summary of participant flow is presented in Figure 1.
The modified Basic Nordic sleep questionnaire (BNSQ) [17], the health and behavior questionnaire,
and participant’s medical history were collected and reviewed by a physician for screening. Insomnia
symptoms were classified according to the DSM-IV-TR criteria (without the criterion of daytime
consequences) from answers to the modified BNSQ. Individuals were considered to have chronic
insomnia symptoms if one or more of the following symptoms had occurred at least three nights
per week, during the past three months: (1) Difficulty initiating sleep (subjective SOL ≥ 30 min);
(2) Difficulty maintaining sleep (awakening during sleep ≥3 times/night, or difficulty in falling
asleep after nocturnal awakening with total wake after sleep onset ≥30 min); (3) Early morning
awakenings (wake up ≥30 min earlier than desired in the morning and unable to fall asleep again);
(4) Non-restorative sleep [18,19].
Exclusion criteria were: (1) other sleep disorders include moderate or severe apnea
(Apnea-hypopnea index, AHI ≥ 15), restless leg syndrome and periodic leg movement disorder
(periodic leg movement arousal index > 15), narcolepsy, REM behavior disorder, and circadian rhythm
disorder; (2) Medical history during the past three years related to diseases such as cardiovascular
disease, heart failure, liver disease, and cancer; (3) Current diagnosis of major depression; (4) History
of other major mental illness or substance abuse; (5) History of cognitive impairment and major
neurological disorders; (6) History of eating disorders; (7) Taking special diet at the moment; (8) Chronic
pain conditions; (9) Regular use of sedatives, hypnotics, and painkillers; (10) Shift work [12].
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Figure 1. Participant flow of the study. 
2.2. Measurements 
All measurements were carried out before randomization, and after the six‐month intervention 
period. In addition, nutrient intake and anthropometry were measured at three months. 
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behavior  questionnaire. Age  of  onset  of  insomnia  and  occurrences  of  insomnia  symptoms were 
elicited with the baseline modified BNSQ. 
2.2.2. Energy Consumption and Nutrients Intake 
A  three‐day  diet  diary  (two  weekdays  and  one  weekend)  collected  the  type,  item,  and 
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calories  (E%) were carried out by  the Micro‐Nutrica software  (The Social  Insurance  Institution of 
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Figure 1. Participant flow of the study.
2.2. Measurements
All measurements were carried out before randomization, and after the six-month intervention
period. In addition, nutrient intake and anthropometry were measured at three months.
2.2.1. Descriptive Characteristics
Age, education, employment, and smoking habits were elicited at baseline with the health and
behavior questionnaire. Age of onset of insomnia and occurrences of insomnia symptoms were elicited
with the baseline modified BNSQ.
2.2.2. Energy Consumption and Nutrients Intake
A three-day diet diary (two weekdays and one weekend) collected the type, item, and estimated
portion of all food and dri k intake during each day. A chiving of diet information, calculation of
nutrients intake, total lories, and proport ons of energy-yielding nutrients i tot l alories (E%) were
carried out by the Micro-Nutrica software (The Social Insurance Institution of Finland, Turku, Finland).
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2.2.3. Anthropometry and Fat Mass
All anthropometric measurements were performed after overnight fasting (12 h). Height was
measured to the nearest 0.5 cm using a fixed wall scale. Weight was determined to the nearest
0.1 kg using a calibrated physician weight scale. BMI was calculated as weight (kg) per height2 (m2).
Neck, chest, waist, and hip circumferences were determined to the nearest 0.1 cm by a measuring tape
using standardized procedures, and the average value of three measurements was taken for analysis.
Blood pressure were measured using an oscillometric monitor in sitting position after five-minute
resting, average value of three measurements was retained. Fat mass was determined using dual
energy X-ray densitometry (DXA; Prodigy, GE Lunar, Madison, WI, USA).
2.2.4. Energy Expenditures
A seven-day physical activity diary was collected on the same days as sleep measurements.
The diary recorded primary living activity at 30-min intervals over 24 h. Energy expenditures were
calculated as metabolic equivalent multiplied by minutes per day (MET min/day), according to
the 2011 Compendium of Physical Activities [20]. Expenditures were categorized into exercise and
recreational activity (e.g., walking a dog, berry picking), livelihood physical activity (e.g., personal
care, housework, commuting, occupational activities), as well as sedentary behaviors (METs ≤ 1.5
while in a sitting or reclining posture) and sleep [21].
2.2.5. Objective Sleep Measurement
Home-based objective sleep data were collected by an unobtrusive online sleep monitoring
system (Beddit pro; Beddit Ltd., Espoo, Finland). The system included a piezoelectric bed sensor.
Ballistocardiographic signals were sampled by the piezoelectric sensor at 140 Hz and simultaneously
uploaded to a web server through the Internet, where sleep/wake status was classified in 30-s epochs
based on heart rate variability, respiration rate variability, and binary actigram [22]. An ambient
brightness sensor, included in the system, was placed in the bedroom for determining lights-out time.
For participants who had a bed partner, sensor attachment was considered to avoid overlapping
measurements. Participants were instructed to mention conditions that might have affected the
measurements, such as children and pets in the bedroom, in the sleep diary. Measurement was set
automatically to start each evening at 18:00, and end at noon the next day. Total sleep time (TST),
SOL (determined as the duration from being present in bed with lights out to the first five minutes of
consecutive sleep) [23], wakefulness after sleep onset (WASO), and sleep efficiency (SE) were obtained
for each night. Sleep was measured for seven nights, including two weekends. Measurements
were taken within 14 days both before and after the six-month study period. For analyses, average
values across the nights were used; at least five nights’ valid data at both baseline and six months
were needed. Validation of the sleep/wake in 30-s epochs was carried out against two-night
polysomnography measurement (31 subjects with insomnia complaints, age (±SD) = 51.8 ± 8.4 years,
BMI = 30.9 ± 4.8 kg/m2). Correlations in sleep outcomes were obtained as follow: TST (Pearson’s
r = 0.85, p < 0.001), SOL (Pearson’s r = 0.81, p < 0.001), WASO (Kendall’s tau-b = 0.74, p < 0.001),
SE (Kendall’s tau-b = 0.68, p < 0.001) [16].
2.2.6. Sleep Diary and Modified BNSQ
The seven-night sleep diary was collected on same nights with objective sleep measurement.
Items included time of going to bed, estimated time of falling asleep, number of nocturnal awakenings,
final waking-up time, morning-rated subjective sleep quality, fatigue upon awakening, nap duration,
and other issues related with sleep. The average values for the recorded nights were used for analyses.
Epworth sleepiness scale (ESS) score [24], Rimon’s brief depression scale score [25], insomnia symptom
frequency, and other subjective sleep assessment results were elicited by the modified BNSQ.
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2.3. Randomization
After the baseline measurements, participants were randomized and allocated into the diet
intervention or control group, by an external statistician. Randomization was stratified by age and
BMI (≤ or >medians) with a block size of 5, using SAS v. 9.2, (SAS Institute, Cary, NC, USA).
2.4. Interactive Diet Intervention
A six-month individualized diet intervention program was made according to the three-day
diet diary results and BMI at baseline. Individualized programs were introduced to each participant
face-to-face by study nutritionists on the first day of intervention. Diet suggestions were made
according to the Finnish Nutrition Recommendations [26]. Suggested proportions of energy-yielding
nutrients were: 40%–45% of carbohydrate in total daily energy intake (E%) with <5 E% sucrose;
35–40 E% total fat with ≤10 E% saturated fatty acids (SFA), 15–20 E% monounsaturated fatty acids
(MUFA), and 5–10 E% polyunsaturated fatty acids (PUFA); and 20 E% protein [26]. In addition, greater
consumption of dietary fiber, vitamin A, vitamin D, vitamin E, B vitamins, vitamin C, magnesium,
and potassium was recommended through selected food options (cereals, vegetables, fruits, berries,
nuts, legumes, mushrooms, etc.). Participants with overweight and obesity (n = 27) were advised to
gradually reduce their daily energy intake by 300–500 kcal during the first three months, with a target
of reducing body weight by 3 kg. After this period, calorie intake was suggested to remain at the
reduced level. Two intermediate face-to-face counseling sessions were held in the first and the fourth
month of the intervention. Each intermediate session involved individualized diet counseling with a
nutritionist, and a cooking course in which examples of meals that fulfilled the nutritional criteria of
this study were introduced.
During the intervention, an online diet and nutrition counseling service (MealTracker, Wellness
Foundry Holding Ltd., Helsinki, Finland) was utilized for supervising individuals’ dietary intake
and providing diet suggestions. Participants were instructed to photograph all daily dietary intakes
(including drinks) using a smartphone or a digital camera, and upload all photos to the server 1–3 days
per week during the intervention. The photos were uploaded via a mobile application, or through
the service’s website. According to the uploaded photos, a nutritionist assessed each individual’s
daily calorie intake and consumptions of nutrients. Individualized feedback including dietary intake
facts and instructions for diet adjustment in the upcoming days was thus formulated and sent to
participants via mobile text message and e-mail each day with uploaded information. Diet photos
were saved in each participant’s account in the server, which was only accessible to the participant
and the nutritionist. A training session for taking and uploading diet photos was held prior to the
intervention. All participants in the diet group were able to use the service correctly.
2.5. Control Group
Controls were instructed to keep their habitual, pre-recruitment lifestyle for six months. They were
given an opportunity to participate in the diet plus exercise intervention program for three months
after the study period.
2.6. Statistical Analysis
The estimated change of the objective SOL was based on published data [16,27]. Statistical power
was over 80% to detect a 30% lowered SOL in the diet group from baseline, and no change of SOL in
the control group, with the unbalanced allocation of 28 and 21 participants in each randomized group.
Analyses were carried out following the intention-to-treat principle. For participants with missing
or incomplete values at follow-ups, the last observed values were carried forward. All analyses were
performed using IBM SPSS statistics version 20 (SPSS, Inc., Chicago, IL, USA). All tests were two-tailed;
a p value less than 0.05 was set as significant. The Shapiro–Wilk W test and Levene’s test were used
to examine the normality and homogeneity, respectively. Skewed data were transformed by natural
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logarithm. Baseline differences between groups were evaluated by one-way analysis of variance
(ANOVA), or Pearson’s χ2 test. Time-by-group differences were evaluated by analysis of covariance
(ANCOVA), controlling for the baseline values. Within-group differences were evaluated by repeated
measures ANOVA, followed with Bonferroni corrections for multiple comparisons. In addition,
Pearson’s correlation coefficients were calculated between changes from baseline to six months for
selected variables.
3. Results
Baseline descriptive characteristics by group are given in Table 1. Retention rates between diet
and control groups were comparable (Diet = 26/28, Control = 19/21, p = 0.579, Fisher’s exact test).
Table 1. Descriptive characteristics at baseline.
Diet (n = 28) Control (n = 21)
p #
Mean (95% CI) Mean (95% CI)
Age (year) 51.0 (47.3 to 54.8) 52.6 (48.0 to 57.2) 0.592
Age when insomnia complaint started (year) 37.4 (33.1 to 41.6) 39.8 (33.7 to 46.0) 0.482
Height (cm) 178.9 (177.0 to 180.8) 178.3 (175.6 to 180.9) 0.696
Weight (kg) 93.8 (89.2 to 98.4) 93.1 (85.2 to 100.9) 0.860
BMI (kg/m2) 29.4 (27.9 to 30.8) 29.2 (27.2 to 31.2) 0.879
Systolic blood pressure (mmHg) 142.8 (139.0 to 146.6) 140.7 (135.2 to 146.3) 0.513
Diastolic blood pressure (mmHg) 88.8 (84.9 to 92.6) 91.4 (86.7 to 96.1) 0.363
Occurrences Percentage Percentage
Difficulty initiating sleep 42.9 42.9 1.000
Difficulty maintaining sleep 57.1 76.2 0.166
Early morning awakenings 32.1 23.8 0.523
Non-restorative sleep 39.3 42.9 0.801
Smoking presently 14.3 19.0 0.655
At least tertiary degree education 82.1 95.2 0.166
Employed 82.1 71.4 0.374
# One-way ANOVA or Pearson’s χ2 test.
3.1. Compliance with Diet Interventions
On average, participants in the diet group who attended the six-month follow-up measurements
uploaded 1.9 ± 1.1 (SD) days per week during intervention. All of these participants attended all
three counseling sessions. Two participants dropped out during the first month of the study, both due
to the unwillingness to change diet. There were no diet photos uploaded from the participants who
dropped out.
3.2. Energy Consumption and Nutrient Intake
Within the diet group, total energy intake was reduced at six months compared to baseline
(p = 0.006, Figure 2); however, changes in other nutrients were not detected. Total energy intake
was reduced at three months in both groups (p = 0.001 and 0.012, respectively). Proportions of
energy-yielding nutrients in total calories did not show significant change in either group. Compared
to the controls, the diet group had greater intakes of potassium (2158 vs. 1806 mg/1000 kcal, p = 0.029,
ANCOVA controlling for baseline) and magnesium (219 vs. 193 mg/1000 kcal, p = 0.036, ANCOVA
controlling for baseline) at three months (not shown in figure).
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Table 2. Anthropometry, fat mass, and energy expenditures at baseline and follow‐ups. 
  Diet  Control 
Baseline  3 Months  6 Months Baseline 3 Months  6 Months
Anthropometry   
Weight (kg)  93.8 (89.2 to 98.4)  92.7 (88.3 to 97.0) # 
92.7 (88.1 to 
97.4) # 
93.1 (85.2 to 
100.9) 
93.5 (85.5 to 
101.5) # 
94.4 (86.3 to 
102.5) *,# 
Neck circumference 
(cm)  42.0 (41.0 to 43.0) 
41.9 (40.9 to 
43.0) 
42.2 (41.3 to 
43.2) 
41.9 (40.6 to 
43.3) 
42.0 (40.5 to 
43.4) 
42.6 (41.2 to 
44.0) * 
Chest circumference 
(cm) 
109.4 (106.8 to 
112.0) 
109.2 (106.5 to 
111.9) 
109.7 (106.9 to 
112.5) 
107.7 (102.6 to 
112.9) 
108.0 (102.9 
to 113.1) 
109.5 (104.5 to 
114.5) * 
Waist circumference 
(cm) 
106.6 (102.9 to 
110.2) 
106.1 (102.7 to 
109.4) 
105.9 (102.4 to 
109.4) # 
105.0 (99.9 to 
110.1) 
105.4 (99.9 to 
110.8)   
106.7 (101.3 to 
112.2) *,# 
Hip circumference (cm)  104.5 (101.9 to 
107.1) 
103.1 (100.1 to 
106.1) 
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102.7 (98.6 to 
106.7) 
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107.3) 
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108.1) 
Fat mass 
Total fat mass (kg)  27.5 (24.2 to 30.7)  n/a  26.8 (23.5 to 30.2) # 
28.0 (23.6 to 
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28.9 (24.0 to 
33.8) *,# 
Trunk fat mass (kg)  17.6 (15.6 to 19.6)  n/a  17.2 (15.1 to 
19.3) 
17.7 (14.5 to 
20.8)  n/a 
18.2 (14.9 to 
21.5) * 
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min/day) 
2346.1 (2254.9 to 
2437.3)  n/a 
2398.8 (2299.7 
to 2498.0) 
2341.1 (2224.0 
to 2458.1)  n/a 
2322.6 (2210.0 
to 2435.3) 
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recreational physical 
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226.7 (150.8 to 
302.6)  n/a 
292.5 (194.5 to 
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1006.5)  n/a 
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Figure 2. Daily c lorie intake by three-day i iary at baseline vs. three and six months.
3.3. Anthropometry, Fat Mass, and Energy Expenditures
Body weight, total fat mass, and waist circumference decreased significantly in the diet group
compared to the control group (p = 0.043 to 0.009, Table 2). No sig ificant changes in physical activity,
sedentary time, r total energy expenditure were found in either group during the intervention.
Table 2. Anthropometry, fat mass, and energy expenditures at baseline and follow-ups.
Diet Control
Baseline 3 Months 6 Months Baseline 3 Months 6 Months
Anthropometry
Weight (kg) 93.8(89.2 to 98.4)
92.7
(88.3 to 97.0) #
92.7
(88.1 to 97.4) #
93.1
(85.2 to 100.9)
93.5
(85.5 to 101.5) #
94.4
(86.3 to 102.5) *,#
Neck circumference (cm) 42.0(41.0 to 43.0)
41.9
(40.9 to 43.0)
42.2
(41.3 to 43.2)
41.9
(40.6 to 43.3)
42.0
(40.5 to 43.4)
42.6
(41.2 to 44.0) *
Chest circumference (cm) 109.4(106.8 to 112.0)
109.2
(106.5 to 111.9)
109.7
(106.9 to 112.5)
107.7
(102.6 to 112.9)
108.0
(102.9 to 113.1)
109.5
(104.5 to 114.5) *
Waist circumference (cm) 106.6(102.9 to 110.2)
106.1
(102.7 to 109.4)
105.9
(102.4 to 109.4) #
105.0
(99.9 to 110.1)
105.4
(99.9 to 110.8)
106.7
(101.3 to 112.2) *,#
Hip circumference (cm) 104.5(101.9 to 107.1)
103.1
(100.1 to 106.1)
103.5
(100.4 to 106.7)
102.7
(98. t 106.7)
103.5
(99.6 to 107.3)
104.0
(100.0 to 108.1)
Fat mass
Total fat mass (kg) 27.5(24.2 to 30.7) n/a
26.8
(23.5 to 30.2) #
28.0
(23.6 to 32.5) n/a
28.9
(24.0 to 33.8) *,#
Trunk fat mass (kg) 17.6(15.6 to 19.6) n/a
17.2
(15.1 to 19.3)
17.7
(14.5 to 20.8) n/a
18.2
(14.9 to 21.5) *
Energy expenditures
Total expenditure ( ET min/day) 2346.1(2254.9 to 2437.3) n/a
2398.8
(2299.7 to 2498.0)
2341.1
(2224.0 to 2458.1) n/a
2322.6
(2210.0 to 2435.3)
Exercise and recreational physical
activity (MET min/day)
226.7
(150.8 to 302.6) n/a
292.5
(194.5 to 390.4)
249.5
(145.2 to 353.8) n/a
254.3
(151.9 to 356.7)
Household physical activity
(MET min/day)
840.9
(675.4 to 1006.5) n/a
845.4
(689.9 to 1000.9)
803.0
(631.5 to 974.5) n/a
751.6
(548.6 to 954.6)
Sedentary behaviors (MET min/day) 846.7(739.0 to 954.4) n/a
801.7
(706.1 to 897.3)
824.6
(737.1 to 912.1) n/a
845.0
(758.3 to 931.7)
Data are shown as mean (95% CI); # p < 0.05, compared to the other group, analyses of covariance controlling
for baseline values; * p < 0.05, compared to the baseline values, repeated measures ANOVA with Bonferroni
post hoc comparisons.
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3.4. Objective Sleep Parameters
At baseline, the valid objective sleep data for analyzing were on average 6.4 ± 1.1 and
6.8 ± 0.6 nights in diet and control groups, respectively. At six months, the corresponding numbers
were 6.4 ± 0.9 and 6.6 ± 0.7. There was no between-group difference in the number of nights analyzed
at baseline or six months (p = 0.110 and 0.613, respectively, one-way ANOVA). Nights marked by
participants as being subject to significant disturbance in the measurement process (such as a pet
sleeping in the bed) were excluded. Results of the objective sleep measurements are given in Figure 3.
Compared to the control group, the diet group showed shorter SOL (p < 0.001) after intervention.
Within the diet group, prolonged TST (p = 0.004), curtailed SOL (p < 0.001), and increased sleep
efficiency were found (p = 0.004) through intervention. In the diet group, change of objective SOL
through intervention did not correlate with changes in body weight or fat mass (both p > 0.05,
Pearson’s r).
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Figure 3. Sleep outcomes by piezoelectric system at baseline and six months.
3.5. Subjective Sleep Assessments
No time-by-group difference was detected among subjective sleep parameters (Table 3). Within the
diet group, nocturnal awakenings (p = 0.035), number of nocturia (p = 0.001), and Rimon’s depression
score (p = 0.029) were reduced compared to the baseline values.
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Table 3. Sleep outcomes by sleep diary and sleep questionnaire at baseline and six months.
Diet Control Time by Group
Baseline 6 Months p Baseline 6 Months p p #
Sleep diary
Sleep onset latency (min) † 21.0 (13.5 to 31.0) 20.0 (13.3 to 23.8) 0.122 21.5 (17.3 to 41.8) 25.0 (15.0 to 42.5) 0.463 0.255
Nocturnal awakenings (numbers/night) 2.3 (1.8 to 2.9) 1.8 (1.3 to 2.4) 0.035 2.6 (1.8 to 3.4) 2.3 (1.8 to 2.8) 0.293 0.305
Nocturia (times/night) 0.8 (0.6 to 1.1) 0.5 (0.3 to 0.6) 0.001 0.7 (0.4 to 0.9) 0.5 (0.3 to 0.8) 0.080 0.075
Morning-rated sleep quality (1–4) a 2.4 (2.1 to 2.7) 2.7 (2.4 to 2.9) 0.094 2.4 (2.2 to 2.5) 2.4 (2.2 to 2.6) 0.785 0.153
Fatigue upon awakening (1–4) b 2.2 (2.0 to 2.4) 2.0 (1.7 to 2.2) 0.062 1.9 (1.6 to 2.1) 2.0 (1.8 to 2.2) 0.300 0.292
Nap (min/day) * 17.1 (11.2 to 23.1) 14.0 (8.1 to 19.9) 0.388 12.5 (4.4 to 20.6) 11.9 (2.2 to 21.6) 0.885 0.957
Sleep questionnaire
Difficulty initiating sleep (1–5) c 2.5 (2.0 to 3.0) 2.3 (1.9 to 2.7) 0.227 2.8 (2.2 to 3.3) 2.7 (2.1 to 3.2) 0.540 0.376
Early morning awakenings (1–5) c 3.0 (2.5 to 3.5) 2.8 (2.2 to 3.3) 0.246 3.0 (2.5 to 3.5) 3.1 (2.5 to 3.7) 0.452 0.182
Sleep less than 5 h in last month (1–6) d 2.9 (2.4 to 3.3) 2.6 (2.1 to 3.1) 0.355 3.0 (2.3 to 3.6) 2.8 (2.2 to 3.3) 0.384 0.718
Habitual sleep duration (h) 6.6 (6.1 to 7.1) 6.7 (6.2 to 7.2) 0.706 6.7 (6.2 to 7.2) 6.6 (6.1 to 7.1) 0.545 0.658
Desired sleep duration (h) 7.9 (7.5 to 8.4) 7.8 (7.3 to 8.3) 0.398 8.1 (7.6 to 8.5) 7.9 (7.5 to 8.3) 0.117 0.776
Epworth sleepiness scale score 6.6 (5.2 to 8.0) 6.3 (4.9 to 7.7) 0.612 8.3 (6.2 to 10.5) 7.4 (5.2 to 9.7) 0.056 0.679
Rimon’s depression score † 5.0 (4.0 to 7.0) 4.0 (1.3 to 6.0) 0.029 4.0 (3.0 to 7.5) 3.0 (2.5 to 5.5) 0.187 0.358
Data are shown as mean (95% CI) unless specified otherwise; † Comparisons under Natural Log transformed data, values are shown as the medians and 25th through 75th percentiles;
# Analyses of covariance controlling for baseline values; * Diet (n = 19), Control (n = 12); a 1 = Very poor; 2 = Quite poor; 3 = Good; 4 = Very good; b 1 = Not fatigued at all; 2 = A little
fatigued; 3 = Quite fatigued; 4 = Very fatigued; c 1 = Never/less than once per month; 2 = Less than once per week; 3 = 1–2 days per week; 4 = 3–5 days per week; 5 = daily or almost
daily; d 1 = 0 night; 2 = 1–5 nights; 3 = 6–10 nights; 4 = 11–15 nights; 5 = 16–20 nights; 6 = more than 20 nights.
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4. Discussion
In this study we found that a six-month diet intervention was associated with reduced body
weight, fat mass, and curtailed objective sleep onset latency among overweight and obese men with
chronic insomnia symptoms.
Previous studies have investigated whether adjusting total energy intake may alter sleep
parameters. A recent study reported that one-week ad libitum feeding with increased calorie
density (high fat diet) resulted in increased sleep/wake fragmentation in mice [11], which indicates
a link between excessive energy consumption and disturbed sleep. A human study of acute diet
alteration in normal sleepers has shown that, compared to limited total energy intake, sleep after ad
libitum feeding was characterized by longer SOL and shorter slow wave sleep [10]. By suggesting
controlled total calorie intake for a period of six months, our study further infers the association
between energy restriction and improved nocturnal sleep parameters such as SOL in individuals with
insomnia symptoms.
Nonetheless, it is not known whether total energy intake or the relative proportion of
energy-yielding nutrients plays the more important role in mediating the effect of diet on sleep.
In this study, subjects who received diet intervention reported significantly reduced total energy
intake. However the proportions of the major categories of energy-yielding nutrients (carbohydrates,
fat, protein) were not significantly changed through intervention. Hence energy reduction per se
with negative energy balance may contribute to faster sleep onset among overweight individuals.
More studies are needed in order to identify whether altering energy proportions without changing
the total calories in the diet has the same effect on sleep among humans. So far, only a few studies have
tested the effects of isocaloric diets with different nutrient composition on sleep and sleepiness. These
studies suggested an association between macronutrient proportion and sleep-related parameters, but
the results are inconclusive due to the small sample size and the non-randomized study nature. A study
dating back to 1975 found less slow wave sleep following a two-day high-carb-low-fat diet than after a
two-day low-carb-high-fat diet [28]. Another study compared the acute effect of high-carb/low-fat
and low-carb/high-fat diets on sleepiness, and found a stronger feeling of sleepiness at 2–3 h following
the former dietary pattern [29].
The mechanisms underlying the association between reduced energy intake and improved
nocturnal sleep parameters remain to be revealed. It is known that diet among overweight and
obese individuals is characterized by a larger proportion of fat in total energy consumption [12].
One study has shown that chronic high fat feeding reduces prepro-orexin level in hypothalamus
in obese mice [30]. Since orexin is an important neuropepitide for maintaining wakefulness and
regulating energy balance, we hypothesize that by reducing total energy intake, orexin signaling in
the hypothalamus is strengthened, which induces more stable wakefulness and less sleep duration
during the daytime. Less daytime sleep may further contribute to better nocturnal sleep, with higher
sleep efficiency [31,32]. In addition, orexin neurons showed impaired thermo-sensitivity after high
calorie density feeding [33], which prolonged sleep onset according to the mechanism that thermo
downregulation triggers sleep. Therefore, we assume that lowering calorie intake may also recover the
blunted thermo response of orexin neurons.
In the present study, we found that subjects in the diet intervention group had a greater intake
of potassium and magnesium than the controls. This was partially in line with earlier reports that
intakes of non-energy-yielding nutrients such as fiber, Vitamin D, potassium, and magnesium are
associated with sleep [10,13,34–36]. Although the mechanisms regarding the role of potassium and
magnesium on sleep regulation are not yet understood, these results suggest we should pay attention
to micronutrients that may affect sleep.
Another noteworthy point in this study is that diet intervention led to lower body weight, fat
mass, and waist circumference, and such contrasts were not just the result of weight and fat mass
reductions in the diet group, but also, more significantly, of increased weight and fat mass among
the controls. These results, together with other evidence, indicate that chronic insomnia symptoms
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contribute to weight gain [37–43]. This process is possibly caused by diet-induced positive energy
balance. We also tested whether diet-induced weight change was associated with changes in objective
sleep parameters; however, no significant correlation was found among dieters in our study. This might
either be due to the small sample size (n = 28 in the diet group) or to the fact that the amount of body
weight alteration is not necessarily related to absolute changes in objective sleep parameters.
The present study was subject to several limitations. First, apart from the objective sleep onset
latency, no time-by-treatment difference was observed in the sleep parameters. Thus, in comparison
with other non-pharmaceutical methods for mitigating insomnia symptoms, such as cognitive
behavioral treatment and aerobic exercise [16,23,27,44], diet intervention may have a weaker treatment
efficacy for insomnia. Nevertheless, as the average weight reduction did not achieve the goal (3 kg)
under such a diet intervention protocol, stricter calorie intake control should be introduced in order to
test the effects of diet on sleep in this population. Moreover, diet information was only recorded at
baseline, three months, and six months, which limited information on actual nutrient intake during
intervention. Finally, we did not exclude participants with mild sleep apnea (5 ≤ AHI < 15) due to the
high prevalence of this symptom among overweight and obese men (up to 61.4%) [45]. Hence, it is
possible that the improvement in sleep was partially due to improvements in sleep breathing.
To our knowledge, this is the first randomized controlled study investigating the effects of
diet intervention on sleep among individuals with insomnia symptoms. The results suggest that a
six-month diet intervention with reduced energy intake and recommended nutrient composition
reduces objective SOL among overweight and obese men with chronic insomnia symptoms.
The findings of the present study provide new evidence for the potential role of dietary interventions
in overweight and obese men with insomnia.
5. Conclusions
Modest energy restriction and optimized nutrient composition shorten sleep onset latency in
overweight and obese men with insomnia symptoms.
Supplementary Materials: The following are available online at http://www.mdpi.com/2072-6643/8/11/751/s1,
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baseline and six months.
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